FdaApplication
NDA 214919
Identifiers
- fda_app_no: NDA214919
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | NDA |
| approval_date | 2022-04-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GLYCOPYRROLATE | GLYCOPYRROLATE | 0.6MG/3ML (0.2MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
1 product